3 Canadian Cannabis Stocks On A Roll Recently
Sean Mason, SmallCapPower.com | May 14, 2020 02:04AM ET
The cannabis sector has been seen as less susceptible to a COVID-19 related economic slowdown as its consumers either need marijuana medically or are highly reluctant to stop using it recreationally. While some of the bigger players, such as Aurora Cannabis (NYSE:ACB), (TSX:NYSE:ACB) and Cronos Group (NASDAQ:CRON), (TSX:CRON) have seen their share price suffer lately, the smaller Canadian cannabis stocks we’ve dug up have experienced the best upward momentum during the past month.
Indiva (OTC:NDVAF) – $0.445
Indiva a Canadian licensed producer, specializing in creating cannabis derivative products, such as capsules, oils, and edibles, as well as premium pre-rolls and flower, distributing products in seven provinces. The Company also provides production, manufacturing and refinement services to peer partners such as TerrAscend (OTC:TRSSF), (CSE:TER) and The Supreme Cannabis Company (OTC:SPRWF), (TSX:FIRE). On April 23, 2020, Indiva announced preliminary first-quarter 2020 financial and operating results, saying it expects sales to be in the range of $2.0 million to $2.2 million, up from $0.3 million in Q4, reflecting less than two months of edibles sales during the quarter. The Company added that its Bhang chocolate is the #1 selling edible in Ontario. Indiva received its edibles, extracts and topicals sales licence from Health Canada on January 31, 2020.
- One-Month Return: 94%
Aleafia Health (OTC:ALEAF) – $0.63
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company, offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis. Aleafia Health owns three licensed cannabis production facilities, including Canada’s first large-scale, legal outdoor cultivation facility. The Company produces a diverse portfolio of derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents. The Company also maintains a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its education platform FoliEdge Academy. On May 7, 2020, Aleafia Health announced that its indirect subsidiary, Emblem Germany GmbH, has formally submitted its application to German regulators for EU Good Manufacturing Practices certification, which, if successful, would allow for cannabis production and export to the EU market.
- One-Month Return: 80%
Get The News You Want
48North Cannabis (OTC:NCNNF) – $0.195
48North Cannabis is a vertically integrated cannabis company focused on the health and wellness market through cultivation and extraction, as well as the creation of innovative, authentic brands for next-generation cannabis products. 48North is developing formulations and manufacturing capabilities for its own proprietary products, as well as positioning itself to contract manufacture similar products for third parties. 48North operates Good:Farm, a 100-acre organic cannabis farm, which produces organically-grown, sun-grown cannabis. In addition, 48North operates two indoor-licensed cannabis production sites in Ontario. The Company’s portfolio of brands includes Latitude, a women’s cannabis platform; Avitas, a single-strain vaporizer cartridge; Quill, a leader in the manufacturing of beautifully designed, lifestyle-focused and sleek vape products and; Sackville & Co, a leading U.S.-based cannabis brand focused on design-forward cannabis accessories and CBD products. On April 22, 2020, 48North Cannabis announced that it has shipped the first order of its dried flower brand, Fleur du Jour, to the Société québécoise du cannabis for retail sale.
- One-Month Return: 36%
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.